Patients in the US with the ultra-rare disease WHIM syndrome now have their first approved treatment, after X4 Pharma’s Xolremdi was given a green light by the FDA. Oral CXCR4 antagonist ...

The Estate Whim Plantation Museum chronicles the lives of the people who lived and worked on the 18th-century Estate Whim plantation. It's the only sugar plantation museum in the Virgin Islands.

The FDA has started a priority review of X4 Pharma’s mavorixafor, angling to become the first therapy for the rare disease WHIM syndrome, with a decision due by 30th April next year. WHIM (warts ...